The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index; none of the 79 sources its claims cite is checked for support yet.
Moderators of inflammation-related depression: a prospective study of breast cancer survivors
Open accessAbstract
Inflammation has been shown to predict depression, but sensitivity to inflammation varies across individuals. Experimental studies administering potent pro-inflammatory agents have begun to characterize this sensitivity. However, risk factors for inflammation-associated depression in naturalistic contexts have not been determined. The present study examined key psychological and behavioral risk factors (state anxiety, perceived stress, negative affect, disturbed sleep, and childhood adversity) as potential moderators of the relationship between inflammation and depressive symptoms in a prospective longitudinal study of breast cancer survivors. Women with early stage breast cancer were recruited after completing primary cancer treatment (nfinal = 161). Depressive symptoms, inflammatory markers (CRP, IL-6, and sTNF-RII), and key risk factors were assessed post treatment (T1), at 6 and 12-month follow-ups (T2 and T3), and during a final follow-up (TF) 3−6 years after T1; childhood adversity was measured only at T3. Inflammatory markers were combined into a single inflammatory index prior to analyses. Women who reported higher levels of state anxiety, perceived stress, negative affect, and/or sleep disturbance at T1 (post-treatment) exhibited higher depressive symptoms at times when inflammation was higher than typical (interaction βs ranged from .06 to .08; all p s < .014). Results demonstrate the relevance of these risk factors for understanding inflammation-associated depression in a clinical context and could inform targeted strategies for prevention and treatment among at-risk populations.
Overview
CoChat Summary
TL;DR
In a prospective cohort of 161 early-stage breast cancer survivors, post-treatment state anxiety, perceived stress, negative affect, and sleep disturbance moderated the within-person association between inflammation and depressive symptoms over 3–6 years. Childhood adversity did not moderate this association.
Key findings
- Higher post-treatment (T1) state anxiety, perceived stress, negative affect, and sleep disturbance each strengthened the association between person-centered inflammation and depressive symptoms at any given assessment (interaction βs ranged from .06 to .08; all ps < .014).
- Simple slopes showed inflammation was positively associated with depressive symptoms among women at high (+1 SD) levels of state anxiety (b = 0.57, p = 0.004), perceived stress (b = 0.70, p < 0.001), negative affect (b = 0.53, p = 0.007), and sleep disturbance (b = 0.54, p = 0.006), but not at low (−1 SD) or average levels.
- Childhood adversity did not moderate the inflammation–depression association (b = 0.001, β = 0.001, p = 0.94).
- Secondary analyses found effects were primarily driven by sTNF-RII rather than CRP or IL-6, and interactive effects were significant in women of average age (~51.6 years) or younger (~43.5 years) but non-significant in older (~59.7 years) women.
Methods
- Secondary analysis of the Mind Body Study, a prospective longitudinal cohort of women with early-stage breast cancer recruited after primary treatment; final analytic sample was 161 women contributing 544 sampling occasions across T1 (post-treatment), T2 (6 months), T3 (12 months), and TF (3–6 years after T1).
- Inflammatory markers CRP, IL-6, and sTNF-RII were assayed from fasting morning blood samples and combined into a single standardized inflammatory index; depressive symptoms were measured with the BDI-II, and risk factors with STAI, PSS, PANAS negative affect, PSQI, and Risky Families questionnaire (childhood adversity measured only at T3).
- Primary hypotheses used 2-level robust multilevel models with person-centered inflammation at level 1 and T1 risk factors (or T3 childhood adversity) at level 2, testing inflammation × risk factor interactions and simple slopes at −1 SD, mean, and +1 SD, controlling for age, BMI, race, chemotherapy, radiation, endocrine therapy, cancer stage, and surgery type.
Limitations
- Stated: the study excluded clinically depressed individuals at recruitment, which may have limited the range of depressive symptoms; it focused on depressive symptoms rather than onset of major depressive disorder; the assessment schedule was not designed to capture acute effects of diagnosis and treatment; the sample was primarily well-educated White breast cancer survivors, limiting generalizability; risk factor measures overlapped with depressive symptom items; and the design does not address temporality or causality.
- Evident from the text: childhood adversity was measured only at T3, so its lack of moderation may reflect timing or measurement rather than a true absence of effect; the analytic sample was a subset of the parent study and included women more likely to have received endocrine therapy than excluded participants.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
0 Valid · 0 Not valid · 35 Not checked · 62 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“perceived stress (b = −0.25, SE = 0.19, β = −0.04, t(383) = 1.34, p = 0.18, and b = 0.22, SE = 0.14, β = 0.04, t(389) = 1.65, p = 0.09, respectively)”
§ Moderators of inflammation-related depression: a prospective study of breast cancer survivors > Results > Moderators of the link between depressive symptoms and person-centered inflammation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Women who reported higher levels of state anxiety, perceived stress, negative affect, and/or sleep disturbance at T1 (post-treatment) exhibited higher depressive symptoms at times when inflammation was higher than typical (interaction βs ranged from .06 to .08; all ps < .014).”
- Also stated in: § Moderators of the link between depressive symptoms and person-centered inflammation · plain
“sleep disturbance (b = 0.11, SE = 0.04, β = 0.06, t(376) = 2.81, p = 0.005)”
§ Moderators of inflammation-related depression: a prospective study of breast cancer survivors > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Moderators of the link between depressive symptoms and person-centered inflammation · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“levels of the inflammatory index showed a non-significant association with time in months since T1 (b = −0.004, SE = 0.003, β = −0.04, t(399) = 1.34, p = 0.18), suggesting that, across the full sample, inflammation remained relatively stable across time.”
§ Moderators of inflammation-related depression: a prospective study of breast cancer survivors > Results > Stability and temporal effects
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“inflammation was positively associated with depressive symptoms among women who reported high (+1 SD) levels of state anxiety (b = 0.57, SE = 0.20, β = 0.09, t(387) = 2.91, p = 0.004)”
§ Moderators of inflammation-related depression: a prospective study of breast cancer survivors > Results > Moderators of the link between depressive symptoms and person-centered inflammation
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“sleep disturbance (b = −0.23, SE = 0.19, β = −0.04, t(375) = 1.20, p = 0.23, and b = 0.16, SE = 0.13, β = 0.03, t(382) = 1.16, p = 0.25, respectively)”
§ Moderators of inflammation-related depression: a prospective study of breast cancer survivors > Results > Moderators of the link between depressive symptoms and person-centered inflammation
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
49 more claims
Create a free account to see all 97 claims and to verify the 78 references still open.
- It may state two separate claims as one. 19
- Probably not a substantial claim. 30
Statistics that don’t add up
Each reported p-value recomputed from its test statistic and degrees of freedom.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“t(389) = 1.65, p = 0.09”
§ Moderators of inflammation-related depression: a prospective study of breast cancer survivors > Results > Moderators of the link between depressive symptoms and person-centered inflammation
Reported p = .09 · recomputed p = .100
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Doesn’t add upt(389) = 1.65reported p = .09 · recomputed p = .100
“t(389) = 1.65, p = .09”
- Consistentχ²(1) = 7.6reported p = .006 · recomputed p = .006
“X2(1, N = 191) = 7.6, p = .006”
- Consistentt(442) = 1.5reported p = .13 · recomputed p = .134
“t(442) = 1.5, p = .13”
- Consistentt(399) = 1.34reported p = .18 · recomputed p = .181
“t(399) = 1.34, p = .18”
- Consistentt(153) = 11.97reported p < .001 · recomputed p < .001
“t(153) = 11.97, p < .001”
24 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Moderators of inflammation-related depression: a prospective study of breast cancer survivors > Results > Associations between depressive symptoms, risk factors, and markers of inflammation
“T1 levels of the inflammatory index (and each inflammatory marker) were not significantly correlated with T1 risk factors (r range: −0.07−0.16), but were positively correlated with childhood adversity (r = 0.19).”
§ Moderators of inflammation-related depression: a prospective study of breast cancer survivors > Results > Sample characteristics
“| 8. CRP (mg/L) | 2.14 | 2.83 | 0.07 | 0.07 | 0.06 | −0.05 | 0.12 | −0.00 | 0.59** | | |”
Citations
Cites
A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
Development and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.01.011 · Cited by 2,779
Causal Relationship Between Stressful Life Events and the Onset of Major Depression
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.6.837 · Cited by 2,566
Cited by
Bower, J. E., & Kuhlman, K. R. (2023) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-080621-045153 · Cited by 153
Self-citationCancer‐related inflammation and depressive symptoms: Systematic review and meta‐analysis
McFarland, D. C., Doherty, M. J., Atkinson, T. M., O’Hanlon, R., BREITBART, W. S., Nelson, C. J., & Miller, A. H. (2022) · Cancer · doi:10.1002/cncr.34193 · Cited by 97
Bower, J. E., Radin, A. S., & Kuhlman, K. R. (2022) · Behaviour Research and Therapy · doi:10.1016/j.brat.2022.104104 · Cited by 45
Self-citationNeuroprotective Effects of Phenolic Antioxidant Tert-butylhydroquinone (tBHQ) in Brain Diseases
Liu, X., Yang, L., Zhang, G., & Ling, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03370-3 · Cited by 28
Kaempferol Improves Breast Cancer-Related Depression through the COX-2/PGE2 Pathway
Zhu, Q., Han, Y., He, Y., Fu, Y., Yang, H., Chen, Y., & Shi, Y. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2811311 · Cited by 28
Metadata
- Authors
- Manigault, A. W., Ganz, P. A., Irwin, M. R., Cole, S. W., Kuhlman, K. R., & Bower, J. E.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Manigault, Andrew W.
- ORCID
- Venue
- Translational Psychiatry
- Published
- 2021-12-06
- Volume
- 11
- Issue
- 1
- Pages
- 615-615
- ISSN
- 2158-3188 (ISSN-L)
- PMC
- PMC8648787
- OpenAlex
- W4200244638
- Cited by
- 29
- References
- 79
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 3 · 2023: 8 · 2022: 6
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Translational Psychiatry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (T32MH015750, K08MH112773)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01-CA10950)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- inflammation, depression, breast cancer survivors, inflammatory markers, C-reactive protein, interleukin-6, soluble TNF receptors, state anxiety, perceived stress, negative affect, sleep disorders, childhood adversity, moderators, inflammatory indices, depressive symptoms
- MeSH terms
- Cancer Survivors, Breast Neoplasms, Depression, Female, Humans, Inflammation, Longitudinal Studies, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Moderators of inflammation-related depression: a prospective study of breast cancer survivors. https://app.cochat.ai/papers/10.1038/s41398-021-01744-6
- The paper
- Manigault, A. W., Ganz, P. A., Irwin, M. R., Cole, S. W., Kuhlman, K. R., & Bower, J. E. (2021). Moderators of inflammation-related depression: a prospective study of breast cancer survivors. Translational Psychiatry. https://doi.org/10.1038/s41398-021-01744-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.